Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study.
Kato N, Kudo M, Tsuchiya K, Hagihara A, Numata K, Aikata H, Inaba Y, Kondo S, Motomura K, Okano N, Ikeda M, Morimoto M, Kuroda S, Kimura A.
Kato N, et al. Among authors: ikeda m.
Hepatol Res. 2023 May;53(5):409-416. doi: 10.1111/hepr.13876. Epub 2023 Jan 23.
Hepatol Res. 2023.
PMID: 36601972